4:00pm – 6:30pm
S14B Injector Competence Training – Part 2
Advanced/Combination Injection Techniques with Neurotoxins and the Array of FDA-Approved Dermal Fillers
2.5 CME credits
Registration fee: $175
Special Note: You are eligible to register for this course without registering for S14A (Basic) ONLY if you attended The Aesthetic Society’s Nurse Injector Competence Training Course held in either San Diego (2022), Miami Beach (2023) or Vancouver (2024).
Co-Chairs:  Z. Paul Lorenc, MD and Miles Graivier, MD
lorenc@lorenc.com
Additional Faculty: David Hill, MD, Kathy Jones, RN and Karen Menard, RN
Level: Comprehensive Organization: Didactic including live patient demonstrations
Course Description:
Designed for nurse, nurse practitioner, and physician assistant injectors, this course offers an in-depth review of the treatment rationale and clinical applications for neuromodulators and FDA-approved hyaluronic acid (HA) dermal fillers. Emphasizing the critical role of anatomy, the course guides participants through the aesthetic analysis and safety consideratioans, focusing on high-risk injection areas in the face. A thorough discussion on recognizing and managing vascular occlusion includes a presentation of various treatment options. Live patient demonstrations with neuromodulators and HA fillers provide practical insights, and patient safety is prioritized throughout, with an emphasis on minimizing complications through appropriate injection techniques.

Desired outcomes:

• Explain the key differences among the FDA-approved neuromodulators.
• List the differentiating factors that can influence performance with HA fillers.
• List the danger zones when injecting the face.
• Explain protocols for treating vascular occlusion caused by a filler injection.
• Explain how the different characteristics of HA fillers would impact your decision where to inject in the face.
• Describe how you would approach injecting HA fillers in the glabellar and forehead, based on the danger zones.
• Describe what you will do if a suspected vascular occlusion occurs when injecting near the perioral area.